AJR AJR Integrative Imaging Dec 2008 articles
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goralnik, C.
Right arrow Articles by Haaga,
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goralnik, C.
Right arrow Articles by Haaga, , JR
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
American Journal of Roentgenology, Vol 151, Issue 5, 903-907
Copyright © 1988 by American Roentgen Ray Society


Articles

CT-guided cutting-needle biopsies of selected chest lesions

CH Goralnik, DM O'Connell, SJ el Yousef, and Haaga JR

Department of Radiology, University Hospitals of Cleveland, OH 44106.

In an effort to improve on our diagnostic yield from percutaneous transthoracic biopsy, we used 14-gauge cutting needles in 56 selected patients. These biopsies were preceded by 18-, 20-, or 22-gauge aspirations in 42 patients, allowing a direct comparison of the efficacy of the needle types. Specific diagnoses were made by cutting-needle biopsy in 78% (25/32) of patients with nonlymphoproliferative malignancies, in 73% (8/11) with lymphoma or thymoma, and in 54% (7/13) of patients with benign diseases. In those in whom both aspiration and cutting needles were employed, a higher percentage of specific diagnoses was achieved by cutting-needle biopsy than by aspiration biopsy: 72% vs 64% in nonlymphoproliferative malignancies, 62% vs 12% in the lymphoproliferative group, and 55% vs 22% in benign disorders. Complications were encountered in 20% of all patients studied. This study shows that, for selected chest lesions, CT-guided cutting-needle biopsies can be performed safely and are useful, especially in the diagnosis of lymphoproliferative or benign disease.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Roentgenol.Home page
T. J. Kim, J.-H. Lee, C.-T. Lee, S. H. Jheon, S. W. Sung, J.-H. Chung, and K. W. Lee
Diagnostic Accuracy of CT-Guided Core Biopsy of Ground-Glass Opacity Pulmonary Lesions
Am. J. Roentgenol., January 1, 2008; 190(1): 234 - 239.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
H. T. Winer-Muram
The solitary pulmonary nodule.
Radiology, April 1, 2006; 239(1): 34 - 49.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
W.-Y. Liao, M.-Z. Chen, Y.-L. Chang, H.-D. Wu, C.-J. Yu, P.-H. Kuo, and P.-C. Yang
US-guided Transthoracic Cutting Biopsy for Peripheral Thoracic Lesions Less than 3 cm in Diameter
Radiology, December 1, 2000; 217(3): 685 - 691.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1988 by the American Roentgen Ray Society.